Roberto Verna1,2*, Daniela Maria Capuano2 and Giuseppe Recchia3
1World Association of Societies of Pathology and Laboratory Medicine, Italy
2Department of Experimental Medicine, Sapienza University of Rome, Italy
3SKF Foundation and DaVinci Start Up, Verona and Milano, Italy
*Corresponding Author: Roberto Verna, World Association of Societies of Pathology and Laboratory Medicine and Department of Experimental Medicine, Sapienza University of Rome, Italy.
Received: January 30, 2019; Published: February 08, 2020
Although every laboratorian knows that clinical diagnosis is made for at least 70% by laboratory data, and in some cases of molecular tests also 100%, this concept is not clear to the majority of politicians who try to save money only by reducing the number of tests available, without taking into consideration their informativeness and usefulness; in one word: appropriateness.
The reduced budget in many cases prevents the achievement of an early diagnosis only because the appropriate test is expensive, without considering that such expensive cost could be amortized by a reduced length of stay in hospital.
Citation: Roberto Verna., et al. “The Fate of Laboratory in Digital Health Eve". Acta Scientific Pharmaceutical Sciences 4.3(2020): 16-17.
Copyright: © 2020 Mohd Roberto Verna., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
×
Copyright
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
